MX2009004775A - Nuevos compuestos y metodos para su produccion. - Google Patents

Nuevos compuestos y metodos para su produccion.

Info

Publication number
MX2009004775A
MX2009004775A MX2009004775A MX2009004775A MX2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A MX 2009004775 A MX2009004775 A MX 2009004775A
Authority
MX
Mexico
Prior art keywords
production
diseases
methods
novel compounds
cancer
Prior art date
Application number
MX2009004775A
Other languages
English (en)
Spanish (es)
Inventor
Christine Martin
Original Assignee
Biotica Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0622342.4A external-priority patent/GB0622342D0/en
Priority claimed from GB0720875A external-priority patent/GB0720875D0/en
Application filed by Biotica Tech Ltd filed Critical Biotica Tech Ltd
Publication of MX2009004775A publication Critical patent/MX2009004775A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2009004775A 2006-11-09 2007-11-09 Nuevos compuestos y metodos para su produccion. MX2009004775A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0622342.4A GB0622342D0 (en) 2006-11-09 2006-11-09 Novel compounds and methods for their production
GB0720875A GB0720875D0 (en) 2007-10-24 2007-10-24 Novel compounds and methods for their production
PCT/GB2007/050679 WO2008056188A2 (en) 2006-11-09 2007-11-09 Novel compounds and methods for their production

Publications (1)

Publication Number Publication Date
MX2009004775A true MX2009004775A (es) 2009-05-21

Family

ID=39362724

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004775A MX2009004775A (es) 2006-11-09 2007-11-09 Nuevos compuestos y metodos para su produccion.

Country Status (10)

Country Link
US (1) US8492370B2 (cg-RX-API-DMAC7.html)
EP (1) EP1973883B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010509306A (cg-RX-API-DMAC7.html)
KR (1) KR20090075856A (cg-RX-API-DMAC7.html)
AU (1) AU2007319014B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0718564A2 (cg-RX-API-DMAC7.html)
CA (1) CA2669047A1 (cg-RX-API-DMAC7.html)
ES (1) ES2389740T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009004775A (cg-RX-API-DMAC7.html)
WO (1) WO2008056188A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855192B2 (en) 2007-01-26 2010-12-21 Kosan Biosciences, Inc. Macrolactams by engineered biosynthesis
KR101097850B1 (ko) 2009-02-24 2011-12-23 한국생명공학연구원 젤다나마이신 생합성 조절유전자 변이주 및 이를 이용한 젤다나마이신 생산방법
CN117695374B (zh) * 2024-01-25 2024-09-06 超越健康科技(浙江)有限公司 一种用于治疗帕金森病的生物药物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9401936D0 (en) * 1992-01-06 1994-09-28 Pfizer Process and uses for 4,5-diohydrogeldanamycin and its hydroquinone
EP1472230B1 (en) 2002-02-08 2009-06-17 Conforma Therapeutic Corporation Ansamycins having improved pharmacological and biological properties
RU2484086C9 (ru) 2003-12-23 2013-08-20 Инфинити Дискавэри, Инк. Аналоги бензохинонсодержащих ансамицинов (варианты), способ их получения, фармацевтическая композиция (варианты) и способ лечения рака (варианты)
WO2005061461A1 (ja) * 2003-12-24 2005-07-07 Kyowa Hakko Kogyo Co., Ltd. ヒートショックプロテイン90（hsp90）ファミリー蛋白質阻害剤
WO2006098761A2 (en) 2005-03-11 2006-09-21 The Regents Of The University Of Colorado Hsp90 inhibitors, methods of making and uses therefor
AU2006263111A1 (en) * 2005-06-29 2007-01-04 Kyowa Hakko Kirin Co., Ltd. Benzenoid ansamycin derivative
JP2009521423A (ja) 2005-12-24 2009-06-04 バイオチカ テクノロジー リミテッド 抗癌剤として有用な２１−デオキシマクベシン類似体
CN101012196A (zh) 2006-12-27 2007-08-08 中国人民解放军军事医学科学院毒物药物研究所 芳香化格尔德霉素类衍生物及其制备方法和用途
US7855192B2 (en) 2007-01-26 2010-12-21 Kosan Biosciences, Inc. Macrolactams by engineered biosynthesis

Also Published As

Publication number Publication date
JP2010509306A (ja) 2010-03-25
KR20090075856A (ko) 2009-07-09
WO2008056188A3 (en) 2008-07-31
BRPI0718564A2 (pt) 2014-03-11
AU2007319014A1 (en) 2008-05-15
CA2669047A1 (en) 2008-05-15
US8492370B2 (en) 2013-07-23
EP1973883A2 (en) 2008-10-01
ES2389740T3 (es) 2012-10-31
US20110021481A1 (en) 2011-01-27
EP1973883B1 (en) 2012-07-11
AU2007319014B2 (en) 2013-03-28
WO2008056188A2 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
PH12012500497A1 (en) Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs
MY148860A (en) Fused amino pyridine as hsp90 inhibitors
MX2010002312A (es) Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis.
TW200508201A (en) Novel process for the preparation of roflumilast
NZ708727A (en) Conjugate compounds
MX2011014029A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida.
MY186456A (en) Quinazoline carboxamide azetidines
WO2008095086A3 (en) Topiramate plus naltrexone for the treatment of addictive disorders
GEP20115293B (en) Isolated extract of walnuts, process for its obtaining and its use
EA201170699A1 (ru) Тетразамещенные пиридазины в качестве антагонистов пути hedgehog
UA102515C2 (ru) Новая лекарственная форма
EP2416795A4 (en) COGNITIVE DECLINE INHIBITORS
MX2009000991A (es) Uso de escina.
UA97401C2 (ru) Экструдат с улучшенной маскировкой вкуса
WO2007128829A3 (en) 18,21-didesoxymacbecin derivatives for the treatment of cancer
AU2013212209A8 (en) (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
MX2009004775A (es) Nuevos compuestos y metodos para su produccion.
MX2009004777A (es) Derivados de 18,21-didsesoximacbecina para el tratamiento de cancer.
MX2009009361A (es) Nueva forma de dosificacion.
WO2007113266A3 (en) Novel compounds and methods for their production
WO2007128827A8 (en) 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies
WO2014141169A3 (en) Novel anti-neurodegenerative natural compounds isolated from alpiniae oxyphyllae fructus and total synthesis theirof
UA96574C2 (ru) Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции

Legal Events

Date Code Title Description
FG Grant or registration